BR100 Decreased By (-0.08%)
BR30 Increased By (0.08%)
KSE100 Decreased By (-0.11%)
KSE30 Decreased By (-0.2%)
AGHA 7.53 Decreased By ▼ -0.10 (-1.31%)
BECO 5.11 Decreased By ▼ -0.46 (-8.26%)
BML 58.30 Decreased By ▼ -1.44 (-2.41%)
BOP 34.58 Increased By ▲ 0.18 (0.52%)
CNERGY 13.68 Increased By ▲ 0.57 (4.35%)
CSIL 6.30 Decreased By ▼ -0.11 (-1.72%)
FCCL 57.55 Decreased By ▼ -0.51 (-0.88%)
FFL 16.50 Increased By ▲ 0.27 (1.66%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 7.36 Decreased By ▼ -0.07 (-0.94%)
KOSM 5.98 Decreased By ▼ -0.05 (-0.83%)
LOTCHEM 27.51 Decreased By ▼ -0.16 (-0.58%)
MLCF 101.93 Decreased By ▼ -0.82 (-0.8%)
NBP 203.29 Decreased By ▼ -1.77 (-0.86%)
NCPL 60.47 Increased By ▲ 0.84 (1.41%)
NPL 69.80 Increased By ▲ 1.24 (1.81%)
OGDC 318.48 Decreased By ▼ -0.44 (-0.14%)
PACE 11.12 Increased By ▲ 0.07 (0.63%)
PAEL 42.86 Decreased By ▼ -0.24 (-0.56%)
PIBTL 16.72 Increased By ▲ 0.09 (0.54%)
PPL 230.62 Increased By ▲ 1.17 (0.51%)
PRL 76.73 Increased By ▲ 5.93 (8.38%)
PTC 71.18 Increased By ▲ 0.18 (0.25%)
SSGC 27.10 Decreased By ▼ -0.31 (-1.13%)
TBL 10.28 Decreased By ▼ -0.03 (-0.29%)
TELE 8.56 Increased By ▲ 0.03 (0.35%)
TPL 23.59 Increased By ▲ 0.53 (2.3%)
TPLP 15.45 Decreased By ▼ -0.31 (-1.97%)
TREET 24.51 Decreased By ▼ -0.20 (-0.81%)
TRG 60.09 Decreased By ▼ -0.20 (-0.33%)
World

Study on rodent shows fasting weakens cancer

Published Updated

 WASHINGTON: Early research on mice with cancer shows that fasting may weaken tumors and help chemotherapy work better, scientists said on Wednesday.

While it remains unknown if the same approach could work in humans, or if it would even be safe, researchers said the findings suggest a promising new route of study for improving response to cancer treatment.

In the mice experiments, "the combination of fasting cycles plus chemotherapy was either more or much more effective than chemo alone," said senior author Valter Longo, professor of gerontology and biological sciences at the University of Southern California (USC).

Longo and colleagues previously published findings in 2008 that showed how fasting protected normal cells against chemotherapy in a study that focused on one type of cancer and a single chemo drug.

The latest study expands on that research to show that fasting makes cancer cells more vulnerable, and spanned several different types of cancer in mice.

Types of cancers studied included breast cancer, melanoma, glioma and human neuroblastoma.

All cancers studied showed that fasting combined with chemotherapy improved survival, slowed the growth of tumors and/or limited their spread.

The study appears in the journal Science Translational Medicine.

"We don't know whether in humans it's effective," Longo said, adding that for now fasting should be "off-limits" to cancer patients, although they should feel they can ask their doctors about the possibility.

In 2010, a small study of 10 human cancer patients who tried fasting cycles with their drug treatment showed that they perceived fewer side effects from chemo, according to self-reported data. The study was published in the journal Aging.

The results of a phase 1 trial assessing the safety of fasting two days before and one day after chemotherapy in patients with breast, urinary tract and ovarian cancer, conducted at the USC, have been submitted for presentation at the annual meeting of the American Society of Cancer Oncologists later this year.

"A way to beat cancer cells may not be to try to find drugs that kill them specifically but to confuse them by generating extreme environments, such as fasting that only normal cells can quickly respond to," Longo said.

Copyright AFP (Agence France-Presse), 2012

Comments

Comments are closed for this article.